
UNC0631
CAS No. 1320288-19-4
UNC0631( UNC0631, UNC 0631, UNC-0631 )
Catalog No. M17245 CAS No. 1320288-19-4
UNC0631 is a effectvie histone methyltransferase G9a inhibitor (IC50=4 nM).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 61 | In Stock |
![]() ![]() |
5MG | 101 | In Stock |
![]() ![]() |
10MG | 177 | In Stock |
![]() ![]() |
25MG | 378 | In Stock |
![]() ![]() |
50MG | 556 | In Stock |
![]() ![]() |
100MG | 777 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameUNC0631
-
NoteResearch use only, not for human use.
-
Brief DescriptionUNC0631 is a effectvie histone methyltransferase G9a inhibitor (IC50=4 nM).
-
DescriptionUNC-0631 is a novel G9a inhibitor with excellent potency in a variety of cell lines and excellent separation of functional potency versus cell toxicity. Protein lysine methyltransferase G9a plays key roles in the transcriptional repression of a variety of genes via dimethylation of lysine 9 on histone H3 (H3K9me2) of chromatin as well as dimethylation of nonhistone proteins including tumor suppressor p53.
-
In Vitro——
-
In Vivo——
-
SynonymsUNC0631, UNC 0631, UNC-0631
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorG9a
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number1320288-19-4
-
Formula Weight635.93
-
Molecular FormulaC37H61N7O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 16.67 mg/mL. 26.21 mM; H2O : < 0.1 mg/mL
-
SMILESCOc1c(OCCCN2CCCCC2)cc2nc(nc(NC3CCN(CC4CCCCC4)CC3)c2c1)N1CCCN(CC1)C(C)C
-
Chemical NameN-(1-(cyclohexylmethyl)piperidin-4-yl)-2-(4-isopropyl-1,4-diazepan-1-yl)-6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Liu F, et al. J Med Chem. 2011, 54(17), 6139-6150.
molnova catalog



related products
-
FRAX1036
FRAX-1036 is a effective and selective PAK1 inhibitor.
-
(E)-AG 556
AG 556 is a selective inhibitor of EGFR and blocks LPS-induced TNF-α production.
-
(1R,2R)-Trans-N-Boc-...
Cyclohexanediamine has a potential of anticancer activity.